Section 1. Report Objective, and Methodology
- Scope of Research
- Research Methodology
- Assumptions
- Research Sources
- Primary Research
- Secondary Research
- Paid Sources
Section 2. Report Summary
- Global Market Snapshot, 2020-2030
- Executive Summary by Segments
- Market Overview, By Treatment Type
- Market Overview, By Marketed Brands
- Market Overview, By Distribution Channel
- Market Overview, By Region
Section 3. Key Insights
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Developments
- Leading Brands
- Price Trend Analysis
- Pipeline Analysis
- Porter’s Analysis
- Epidemiology
- Technology Insights
- Impact of COVID-19
Section 4. Global Non-small Cell Lung Cancer Treatment Market By Treatment Type, Market Size, and Revenue Opportunity (USD Billion, 2020-2030)
- Global Industry Overview, By Treatment Type
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Chemotherapy (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Targeted Therapy (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Immunotherapy (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
Section 5. Global Non-small Cell Lung Cancer Treatment Market By Marketed Brand, Market Size, and Revenue Opportunity (USD Billion, 2020-2030)
- Global Industry Overview, By Marketed Brands
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Bevacizumab (Avastin) (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Necitumumab (Portrazza) (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Ramucirumab (Cyramza) (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Nivolumab (Opdivo) (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Atezolizumab (Tecentriq) (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Others (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
Section 6. Global Non-small Cell Lung Cancer Treatment Market By Distribution Channel, Market Size, and Revenue Opportunity (USD Billion, 2020-2030)
- Global Industry Overview, By Distribution Channel
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- Hospital Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Retail Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Online Pharmacies (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
Section 7. Global Non-small Cell Lung Cancer Treatment Market By Region, Market Size, and Revenue Opportunity (USD Billion, 2020-2030)
- Global Industry Overview, By Distribution Channel
- Market Size, US$ Bn
- Market Share Analysis, 2022 and 2030 (%)
- Market Trends and Dynamics
- North America
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Marketed Brands (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- U.S.
- Canada
- Latin America
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Marketed Brands (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Brazil
- Mexico
- Rest of Latin America
- Europe
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Marketed Brands (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Marketed Brands (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- China
- Japan
- South Korea
- India
- ASEAN
- Rest of APAC
- Middle East and Africa
- By Treatment Type (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Marketed Brands (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Distribution Channel (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- By Country (Market Size and Forecast, and Y-o-Y Growth, 2022-2030, (US$ Billion))
- Saudi Arabia
- UAE
- Rest of MEA
Section 8. Company Profiles
- Pfizer Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- AstraZeneca plc
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Eli Lilly and Company
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Boehringer Ingelheim GMBH
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Novartis International AG
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Bristol-Myers Squibb Company
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Merck & Co., Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Johnson & Johnson
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
- Amgen, Inc.
- Company Overview
- Product Portfolio and Performance
- Financial Performance
- Technology Insights
- Strategic Initiatives
Frequently Asked Questions
The current market size of the non-small cell lung cancer (NSCLC) treatment industry is estimated to be US$ 26.2 billion in 2023.
Rising prevalence of NSCLC, increasing demand for targeted therapies, and technological advancements are contributing significantly to the growth of the Non-small Cell Lung Cancer Treatment market.
The key factors hampering the growth of the Non-small Cell Lung Cancer Treatment Market are high cost of treatment and limited access to care in developing countries.
The leading component segment in the Non-small Cell Lung Cancer Treatment Market is targeted therapies.
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche, Johnson & Johnson, Merck, Novartis, Pfizer, Takeda are the major players operating in the Non-small Cell Lung Cancer Treatment Market.
The non-small cell lung cancer treatment market is expected to grow at a CAGR of 8.9% and reach a market size of US$ 47.5 billion by 2030.